• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

Economic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations

Publication
Article
Supplements and Featured PublicationsEconomic Impact of Intravenous Versus Subcutaneous Administration of Infliximab on Health System Finances and Operations

This clinical brief is supported by Celltrion Inc.

© 2025 MJH Life Sciences
AJMC®
All rights reserved.